228 related articles for article (PubMed ID: 7689902)
1. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations.
Costes B; Fanen P; Goossens M; Ghanem N
Hum Mutat; 1993; 2(3):185-91. PubMed ID: 7689902
[TBL] [Abstract][Full Text] [Related]
2. Four new mutations of the CFTR gene (541delC, R347H, R352Q, E585X) detected by DGGE analysis in Italian CF patients, associated with different clinical phenotypes.
Cremonesi L; Ferrari M; Belloni E; Magnani C; Seia M; Ronchetto P; Rady M; Russo MP; Romeo G; Devoto M
Hum Mutat; 1992; 1(4):314-9. PubMed ID: 1284538
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.
Eggerding FA; Iovannisci DM; Brinson E; Grossman P; Winn-Deen ES
Hum Mutat; 1995; 5(2):153-65. PubMed ID: 7538376
[TBL] [Abstract][Full Text] [Related]
4. CFTR gene analysis in cystic fibrosis patients: detection of 91% of molecular defects and identification of the novel mutation D979V.
Plouvier E; Cougoureux E; Sardet A; Tournier G; Aymard P; Feldmann D
Ann Genet; 1997; 40(3):185-8. PubMed ID: 9401110
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical findings in Austrian cystic fibrosis patients with mutations in exon 11 of the CFTR gene.
Greil I; Wagner K; Eber E; Zach M; Rosenkranz W
Wien Klin Wochenschr; 1995; 107(15):464-9. PubMed ID: 7545856
[TBL] [Abstract][Full Text] [Related]
6. Screening for cystic fibrosis in dried blood spots of newborns.
Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
[TBL] [Abstract][Full Text] [Related]
7. Identification of eight mutations and three sequence variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Ghanem N; Costes B; Girodon E; Martin J; Fanen P; Goossens M
Genomics; 1994 May; 21(2):434-6. PubMed ID: 7522211
[TBL] [Abstract][Full Text] [Related]
8. Detection of over 98% cystic fibrosis mutations in a Celtic population.
Férec C; Audrezet MP; Mercier B; Guillermit H; Moullier P; Quere I; Verlingue C
Nat Genet; 1992 Jun; 1(3):188-91. PubMed ID: 1284639
[TBL] [Abstract][Full Text] [Related]
9. CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel.
Zielenski J; Aznarez I; Onay T; Tzounzouris J; Markiewicz D; Tsui LC
Methods Mol Med; 2002; 70():3-19. PubMed ID: 11917532
[No Abstract] [Full Text] [Related]
10. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of the two prevalent mutations in the cystic fibrosis gene in Reunion Island.
Bienvenu T; Bousquet S; Herbulot C; Cartault F; Kaplan JC; Beldjord C
Hum Mutat; 1993; 2(4):306-8. PubMed ID: 7691353
[TBL] [Abstract][Full Text] [Related]
12. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
15. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms.
Audrézet MP; Chen JM; Raguénès O; Chuzhanova N; Giteau K; Le Maréchal C; Quéré I; Cooper DN; Férec C
Hum Mutat; 2004 Apr; 23(4):343-57. PubMed ID: 15024729
[TBL] [Abstract][Full Text] [Related]
16. Single-stranded conformation polymorphism analysis of the CFTR gene in Slovenian cystic fibrosis patients: detection of mutations and sequence variations.
Ravnik-Glavac M; Glavac D; Komel R; Dean M
Hum Mutat; 1993; 2(4):286-92. PubMed ID: 7691352
[TBL] [Abstract][Full Text] [Related]
17. Mutation heterogeneity of cystic fibrosis in France: screening by denaturing gradient gel electrophoresis using psoralen-modified oligonucleotide.
Bienvenu T; Cazeneuve C; Kaplan JC; Beldjord C
Hum Mutat; 1995; 6(1):23-9. PubMed ID: 7550227
[TBL] [Abstract][Full Text] [Related]
18. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
[TBL] [Abstract][Full Text] [Related]
19. Screening for CF mutations in adult cystic fibrosis patients with a directed and optimized SSCP strategy.
Ravnik-Glavac M; Glavac D; Chernick M; di Sant'Agnese P; Dean M
Hum Mutat; 1994; 3(3):231-8. PubMed ID: 7517265
[TBL] [Abstract][Full Text] [Related]
20. Solid phase fluorescent sequencing of the CFTR gene.
Cuppens H; Cassiman JJ
Methods Mol Biol; 2001; 167():63-88. PubMed ID: 11265322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
